marine compounds and cancer: 2017 updates
Clicks: 181
ID: 219828
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
181 views
20 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #169 of 194 articles by views in jixie gongcheng xuebao/journal of mechanical engineering
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 194 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
By the end of 2017, there were seven marine-derived pharmaceutical substances that have been approved by the FDA for clinical use as drugs[...]
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (22 words).
Try re-searching for a better abstract.
| Reference Key |
dyshlovoy2018marinemarine
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Sergey A. Dyshlovoy;Friedemann Honecker |
| Journal | jixie gongcheng xuebao/journal of mechanical engineering |
| Year | 2018 |
| DOI |
10.3390/md16020041
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.